Document is current
Any future updates will be listed below
-
Authors
Ayati, Narjess
McIntosh, Lachlan
Buteau, James
Alipour, Ramin
Pudis, Michal
Daw, Nicholas
Jackson, Price
Hofman, Michael S. http://orcid.org/0000-0001-8622-159X
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 27 April 2024
First Online: 6 May 2024
Declarations
:
: This retrospective study was approved by the Peter MacCallum Cancer Centre Human Ethics & Governance committee (Approval number: HREA/91235/PMCC) and the committee waived the requirement to obtain patient consent.
: All authors have reviewed the final version and consented for publication of the study.
: MSH acknowledged philanthropic/government grant support from the Prostate Cancer Foundation (PCF) funded by CANICA Oslo Norway, Peter MacCallum Foundation, Medical Research Future Fund (MRFF), NHMRC Investigator Grant, Movember, and the Prostate Cancer Foundation of Australia (PCFA). MSH acknowledges research grant support from Novartis (including AAA and Endocyte), ANSTO, Bayer and Isotopia. Consulting fees for lectures or advisory boards from Astellas, AstraZeneca, Janssen, Merck/MSD, Mundipharma and Point Biopharma. The other authors have nothing to disclose.
